IL243510B - A combination of oxycodone and naloxone for use in treating pain in patients suffering from pain and a disease resulting in intestinal dysbiosis and/or increasing the risk for intestinal bacterial translocation

21 members in 16 offices

This recordMember, by publication datePriority claim6 more offices are in the list below

Priority claims
Document	Office	Kind	Date
13177646	European Patent Office (EPO)	A	2013-07-23
2014065816	European Patent Office (EPO)	W	2014-07-23
131776460	–	–	–
EP20130177646	–	–	–
PCTEP2014065816	–	–	–
WO2014EP65816	–	–	–

Family members, oldest first
Document	Office	Kind
CA2918004A1	Canada	A1	2015-01-29
WO2015011189A1	World Intellectual Property Organization (WIPO)	A1	2015-01-29
AU2014295042A1	Australia	A1	2016-02-18
KR20160034352A	Republic of Korea	A	2016-03-29
PH12016500063A1	Philippines	A1	2016-04-04
CN105517551A	China	A	2016-04-20
EP3024461A1	European Patent Office (EPO)	A1	2016-06-01
US2016184293A1	United States of America	A1	2016-06-30
CL2016000170A1	Chile	A1	2016-07-08
MX2016000810A	Mexico	A	2016-08-05
JP2016525138A	Japan	A	2016-08-22
EA201600033A1	Eurasian Patent Organization (EAPO)	A1	2016-10-31
AU2014295042B2	Australia	B2	2017-03-30
NZ716267A	New Zealand	A	2017-05-26
KR20180037074A	Republic of Korea	A	2018-04-10
UA116567C2	Ukraine	C2	2018-04-10
US10071089B2	United States of America	B2	2018-09-11
CA2918004C	Canada	C	2018-11-20
IL243510BThis record	Israel	B	2019-03-31
EP3024461B1	European Patent Office (EPO)	B1	2020-05-13
MY183489A	Malaysia	A	2021-02-22

5 legal events, as the office reported them to INPADOC

Point at a mark for the event

Legal events, newest first
	Event	Code
2021-02-28	Patent not in force due to non-payment of renewal feesMM9K	MM9K
2021-02-28	Patent not in force due to non-payment of renewal feesMM9K	MM9K
2019-09-26	Patent renewedKB	KB
2019-09-26	Patent renewedKB	KB
2019-07-31	Patent grantedGrantedFF	FF

English: A combination of oxycodone and naloxone for use in treating pain in patients suffering from pain and a disease resulting in intestinal dysbiosis and/or increasing the risk for intestinal bacterial translocation
Hebrew: שילוב של אוקסיקודון ונלוקסון לשימוש בטיפול בכאב בחולים הסובלים מכאב וממחלה הגורמת לדיסביוזיס של המעיים ו/או מגדילה את הסיכון לטרנסלוקצית חיידקי מעיים

CPC, 22: A61K31/485
A61K9/2054
A61K9/4866
A61P1/00
A61P1/04
A61P1/16
A61P1/18
A61P13/12
A61P17/02
A61P19/02
A61P25/00
A61P25/04
A61P25/16
A61P29/00
A61P3/04
A61P31/00
A61P31/04
A61P35/00
A61P37/02
A61P37/08
A61P43/00
A61P3/10
Filled: the office’s first classification

A combination of oxycodone and naloxone for use in treating pain in patients suffering from pain and a disease resulting in intestinal dysbiosis and/or increasing the risk for intestinal bacterial translocation